{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:05:50Z","timestamp":1792026350068,"version":"4.4.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.thromres.2023.11.005","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T02:15:28Z","timestamp":1699236928000},"page":"77-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies"],"prefix":"10.1016","volume":"232","author":[{"given":"Alfredo","family":"Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Sofia","family":"De Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Porfidia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.11.005_bb0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","article-title":"Inflammatory bowel disease","volume":"325","author":"Podolsky","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"46","key":"10.1016\/j.thromres.2023.11.005_bb0010","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.thromres.2023.11.005_bb0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.crohns.2012.10.008","article-title":"Clinical presentation of venous thromboembolism in inflammatory bowel disease","volume":"7","author":"Papay","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.thromres.2023.11.005_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ncpgasthep0190","article-title":"Therapy insight: vascular complications in patients with inflammatory bowel disease","volume":"2","author":"Koutroubakis","year":"2005","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410050405","article-title":"Cerebral and retinal vascular complications of inflammatory bowel disease","volume":"5","author":"Schneiderman","year":"1979","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7812\/TPP\/21.031","article-title":"Cerebral venous sinus thrombosis in inflammatory bowel disease: a review of published case reports","volume":"25","author":"Albakr","year":"2021","journal-title":"Perm. J."},{"key":"10.1016\/j.thromres.2023.11.005_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clinimag.2010.03.006","article-title":"Multiple intra-abdominal venous thrombosis in ulcerative colitis: role of MDCT for detection","volume":"35","author":"Lef\u00e8vre","year":"2011","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.thromres.2023.11.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.744505","article-title":"Epidemiology and risk factors of portal venous system thrombosis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"8","author":"Lin","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-2001-17864","article-title":"Acute Budd-Chiari syndrome, portal and splenic vein thrombosis in a patient with ulcerative colitis associated with antiphospholipid antibodies and protein C deficiency","volume":"39","author":"Junge","year":"2001","journal-title":"Z. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2214\/AJR.13.12447","article-title":"Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss inflammatory bowel disease cohort","volume":"203","author":"Vietti Violi","year":"2014","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mob.2000.104199","article-title":"Ovarian vein thrombosis associated with Crohn\u2019s disease: a case report","volume":"182","author":"Marcovici","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0060","first-page":"1","article-title":"Postpartum ovarian vein thrombosis in a 29-year-old woman with ulcerative colitis","volume":"2014","author":"Bhari","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.thromres.2023.11.005_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4254\/wjh.v3.i6.164","article-title":"Budd-Chiari syndrome in a patient with ulcerative colitis and no inherited coagulopathy","volume":"3","author":"Dacha","year":"2011","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0070","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1136\/bcr-2017-222300","article-title":"Budd-Chiari syndrome in a patient with ulcerative colitis","volume":"2018","author":"Bohra","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.thromres.2023.11.005_bb0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00006982-200006000-00022","article-title":"Central retinal vein occlusion in two patients with inflammatory bowel disease","volume":"20","author":"Larsson","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.thromres.2023.11.005_bb0080","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1093\/ibd\/izz086","article-title":"Central retinal vein occlusion: a rare ocular complication of inflammatory bowel disease-a case series","volume":"25","author":"Choi","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.thromres.2023.11.005_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCG.0b013e31818a846e","article-title":"Local thrombolysis: a newer approach to treating inflammatory bowel disease-related thromboembolism","volume":"43","author":"Tabibian","year":"2009","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/hpeds.2014-0041","article-title":"The incidence of catheter-associated venous thrombosis in noncritically ill children","volume":"5","author":"Smitherman","year":"2015","journal-title":"Hosp. Pediatr."},{"key":"10.1016\/j.thromres.2023.11.005_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.1936.00170110025002","article-title":"Extensive arterial and venous thrombosis complicating chronic ulcerative colitis","volume":"58","author":"Bargen","year":"1936","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0025-6196(12)65200-8","article-title":"Vascular complications of inflammatory bowel disease","volume":"61","author":"Talbot","year":"1986","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.thromres.2023.11.005_bb0105","first-page":"680","article-title":"The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"34","author":"Arvanitakis","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","article-title":"Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies","volume":"8","author":"Fumery","year":"2014","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.thromres.2023.11.005_bb0115","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.12294","article-title":"Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease","volume":"37","author":"Yuhara","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2023.11.005_bb0120","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3748\/wjg.v28.i16.1705","article-title":"Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis","volume":"28","author":"Zhang","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0125","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.14309\/ajg.0000000000001237","article-title":"Persistently high rate of venous thromboembolic disease in inflammatory bowel disease: a population-based study","volume":"116","author":"Bernstein","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0135","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/ecco-jcc\/jjab113","article-title":"Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched Cohort Study","volume":"15","author":"Kuenzig","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.thromres.2023.11.005_bb0140","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2023.11.005_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0155","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2023.11.005_bb0160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gut.2003.025411","article-title":"Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?","volume":"53","author":"Miehsler","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0165","first-page":"1","article-title":"Risk factors of venous thromboembolism in inflammatory bowel disease: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5009\/gnl210190","article-title":"Venous thromboembolism risk in Asian patients with inflammatory bowel disease: a population-based Nationwide inception cohort study","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver."},{"issue":"11","key":"10.1016\/j.thromres.2023.11.005_bb0175","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.cgh.2014.02.034","article-title":"Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases","volume":"12","author":"Ananthakrishnan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.thromres.2023.11.005_bb0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MIB.0000000000000007","article-title":"Venous thromboembolism in patients with: inflammatory bowel diseases: a case-control study of risk factors","volume":"20","author":"Scoville","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.thromres.2023.11.005_bb0185","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/MIB.0000000000001218","article-title":"Increased rate of venous thromboembolism in hospitalized inflammatory bowel disease patients with clostridium difficile infection","volume":"23","author":"Bhandari","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.thromres.2023.11.005_bb0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a Nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ecco-jcc\/jjx162","article-title":"Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease: a Meta-analysis","volume":"12","author":"Sarlos","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.thromres.2023.11.005_bb0200","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3390\/jcm9072115","article-title":"Venous thromboembolism in patients with inflammatory bowel disease: the role of pharmacological therapy and surgery","volume":"9","author":"Papa","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","article-title":"International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease","volume":"18","author":"Olivera","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-015-0044-2","article-title":"Thrombosis in inflammatory bowel diseases: what\u2019s the link?","volume":"13","author":"Giannotta","year":"2015","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2023.11.005_bb0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"26","author":"Cheng","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/189341","article-title":"Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function","volume":"2015","author":"Pastorelli","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.thromres.2023.11.005_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Ni","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0235","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","article-title":"The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease","volume":"9","author":"Zuo","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0240","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature18847","article-title":"The microbiome and innate immunity","volume":"535","author":"Thaiss","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2023.11.005_bb0250","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory bowel diseases (IBD) and the microbiome\u2014searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2023.11.005_bb0255","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.3748\/wjg.v21.i29.8787","article-title":"Role of the normal gut microbiota","volume":"21","author":"Jandhyala","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0260","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2023.11.005_bb0265","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2016-312135","article-title":"Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease","volume":"67","author":"Imhann","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0270","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrgastro.2013.35","article-title":"The gastrointestinal mucus system in health and disease","volume":"10","author":"Johansson","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.17.2.375","article-title":"Junctional complexes in various epithelia","volume":"17","author":"Farquhar","year":"1963","journal-title":"J. Cell Biol."},{"issue":"6262","key":"10.1016\/j.thromres.2023.11.005_bb0280","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.thromres.2023.11.005_bb0285","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of intestinal barrier function by microbial metabolites","volume":"11","author":"Ghosh","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0290","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4014\/jmb.2203.03022","article-title":"Leaky gut in IBD: intestinal barrier\u2013gut microbiota interaction","volume":"32","author":"Yu","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0295","first-page":"5140","article-title":"Disturbances of the gut microbiota and microbiota-derived metabolites in inflammatory bowel disease","volume":"14","author":"Hu","year":"2022","journal-title":"Nutr"},{"key":"10.1016\/j.thromres.2023.11.005_bb0300","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0305","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40553","article-title":"Gut microbiota density influences host physiology and is shaped by host and microbial factors","volume":"8","author":"Contijoch","year":"2019","journal-title":"elife"},{"key":"10.1016\/j.thromres.2023.11.005_bb0310","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","article-title":"Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation","volume":"40","author":"Goto","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.thromres.2023.11.005_bb0315","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fimmu.2015.00639","article-title":"The Treg\/Th17 axis: a dynamic balance regulated by the gut microbiome","volume":"6","author":"Omenetti","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0320","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0325","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/gut.46.4.493","article-title":"Butyrate and glucose metabolism by colonocytes in experimental colitis in mice","volume":"46","author":"Ahmad","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0330","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.aninu.2017.08.010","article-title":"Implications of butyrate and its derivatives for gut health and animal production","volume":"4","author":"Bedford","year":"2018","journal-title":"Anim. Nutr."},{"key":"10.1016\/j.thromres.2023.11.005_bb0335","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.thromres.2023.11.005_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-07859-7","article-title":"Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway","volume":"10","author":"Singh","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.thromres.2023.11.005_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105358","article-title":"Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites","volume":"164","author":"Jing","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0350","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep4.1256","article-title":"FXR and TGR5 agonists ameliorate liver injury, steatosis, and inflammation after binge or prolonged alcohol feeding in mice","volume":"2","author":"Iracheta-Vellve","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.thromres.2023.11.005_bb0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2020.03.003","article-title":"The gut microbiome and thromboembolism","volume":"189","author":"Hasan","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0360","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","article-title":"Role of gut microbiota in atherosclerosis","volume":"14","author":"Jonsson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.thromres.2023.11.005_bb0365","article-title":"Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB","volume":"5","author":"Seldin","year":"2016","journal-title":"J. Am. Hear. Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"10.1016\/j.thromres.2023.11.005_bb0370","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","article-title":"Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation","volume":"17","author":"Bennett","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.thromres.2023.11.005_bb0375","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe\u2013targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2023.11.005_bb0385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2018.12.011","article-title":"Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism","volume":"174","author":"Reiner","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0390","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.tcm.2015.03.010","article-title":"Inflammatory bowel disease and risk of coronary heart disease","volume":"25","author":"Rungoe","year":"2015","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0395","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.amjmed.2012.03.015","article-title":"Are patients with inflammatory bowel disease at increased risk of coronary artery disease?","volume":"125","author":"Gandhi","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104458","article-title":"Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease","volume":"146","author":"Kul","year":"2023","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0405","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1007\/s10620-015-3797-3","article-title":"Trimethylamine-N-oxide: a novel biomarker for the identification of inflammatory bowel disease","volume":"60","author":"Wilson","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"11","key":"10.1016\/j.thromres.2023.11.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002699","article-title":"Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack","volume":"4","author":"Yin","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2023.11.005_bb0415","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/eurheartj\/ehz893","article-title":"Low-grade endotoxaemia enhances artery thrombus growth via toll-like receptor 4: implication for myocardial infarction","volume":"41","author":"Carnevale","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2023.11.005_bb0420","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2023.11.005_bb0425","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","article-title":"Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the bruneck study","volume":"34","author":"Wiedermann","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0430","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.thromres.2023.11.005_bb0435","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2004.08.018","article-title":"Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome","volume":"351","author":"Mitaka","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.thromres.2023.11.005_bb0440","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0001-2018","article-title":"Function and biogenesis of lipopolysaccharides","volume":"8","author":"Bertani","year":"2018","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.thromres.2023.11.005_bb0445","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1073\/pnas.1912774117","article-title":"ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2023.11.005_bb0450","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/acs.jafc.9b06294","article-title":"Protective effect of Kaempferol on LPS-induced inflammation and barrier dysfunction in a coculture model of intestinal epithelial cells and intestinal microvascular endothelial cells","volume":"68","author":"Bian","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.thromres.2023.11.005_bb0455","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3389\/fimmu.2018.01704","article-title":"Inhibition of lipopolysaccharide- and lipoprotein-induced inflammation by antitoxin peptide Pep19-2.5","volume":"9","author":"Heinbockel","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2023.11.005_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.thromres.2023.11.005_bb0465","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0470","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.3390\/ijms22126242","article-title":"Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases","volume":"22","author":"Candelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.thromres.2023.11.005_bb0475","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/nu11102277","article-title":"Regulation of gut microbiota and metabolic endotoxemia with dietary factors","volume":"11","author":"Fuke","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.thromres.2023.11.005_bb0480","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3389\/fcimb.2022.1015890","article-title":"Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn\u2019s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets","volume":"12","author":"Khorsand","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0485","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/microorganisms9040697","article-title":"The role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases","volume":"9","author":"Baldelli","year":"2021","journal-title":"Microorg"},{"key":"10.1016\/j.thromres.2023.11.005_bb0490","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.chom.2007.08.002","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp","year":"2007","journal-title":"Cell Host Microbe"},{"issue":"1065","key":"10.1016\/j.thromres.2023.11.005_bb0495","first-page":"1","article-title":"The relationship between gut microbiota and inflammatory diseases: the role of macrophages","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.thromres.2023.11.005_bb0500","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0505","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-1711.2005.01314.x","article-title":"Evidence of toll-like receptor molecules on human platelets","volume":"83","author":"Cognasse","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0510","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1074\/jbc.274.12.7611","article-title":"Bacterial lipopolysaccharide activates nuclear factor-\u03baB through Interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes","volume":"274","author":"Zhang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2023.11.005_bb0515","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s10620-021-07064-5","article-title":"Surgery and the subtype of inflammatory bowel disease impact the risk of venous thromboembolism after hospital discharge","volume":"67","author":"McCurdy","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.thromres.2023.11.005_bb0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41430-020-0681-9","article-title":"Gastrointestinal surgery and the gut microbiome: a systematic literature review","volume":"75","author":"Ferrie","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.thromres.2023.11.005_bb0525","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cgh.2019.07.028","article-title":"Acute venous thromboembolism risk highest within 60 days after discharge from the hospital in patients with inflammatory bowel diseases","volume":"18","author":"Faye","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0530","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.amjsurg.2014.05.025","article-title":"Clostridium difficile increases the risk for venous thromboembolism","volume":"208","author":"Barmparas","year":"2014","journal-title":"Am. J. Surg."},{"issue":"16","key":"10.1016\/j.thromres.2023.11.005_bb0535","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"J. clostridium difficile infection","volume":"372","author":"Daniel","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0540","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1572-0241.2003.04026.x","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"99","author":"Solem","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0545","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1016\/j.csbj.2021.11.037","article-title":"Dysbiosis and relapse-related microbiome in inflammatory bowel disease: a shotgun metagenomic approach","volume":"19","author":"Serrano-G\u00f3mez","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"3","key":"10.1016\/j.thromres.2023.11.005_bb0550","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/gutjnl-2019-318719","article-title":"Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"69","author":"Sokol","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0555","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/ecco-jcc\/jjaa081","article-title":"Early postoperative endoscopic recurrence in Crohn\u2019s disease is characterised by distinct microbiota recolonisation","volume":"14","author":"MacHiels","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.thromres.2023.11.005_bb0560","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrmicro3089","article-title":"The gut microbiota and obesity: from correlation to causality","volume":"11","author":"Zhao","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0565","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fphys.2021.673341","article-title":"Effect of cigarette smoke on gut microbiota: state of knowledge","volume":"12","author":"Gui","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-1971-7","article-title":"Smoking and microbiome in oral, airway, gut and some systemic diseases","volume":"17","author":"Huang","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0575","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fcimb.2021.633242","article-title":"Effects of smoking on inflammatory markers in a healthy population as analyzed via the gut microbiota","volume":"11","author":"Yan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0580","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cell.2017.11.024","article-title":"Our gut microbiome: the evolving inner self","volume":"171","author":"Kundu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2023.11.005_bb0585","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MCG.0000000000000408","article-title":"Antitumor necrosis factor- a therapy is associated with reduced risk of thromboembolic events in hospitalized patients with inflammatory bowel disease","volume":"50","author":"DeFonseka","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111904","article-title":"The influence of biologics on the microbiome in immune-mediated inflammatory diseases: a systematic review","volume":"141","author":"Ruszkowski","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.thromres.2023.11.005_bb0595","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0600","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/JLB.MR0618-213R","article-title":"Platelet TLR4 at the crossroads of thrombosis and the innate immune response","volume":"105","author":"Schattner","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0605","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-8278(05)80501-X","article-title":"Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities","volume":"20","author":"Violi","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0610","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","article-title":"Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis","volume":"109","author":"Violi","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2023.11.005_bb0615","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/gut.43.3.428","article-title":"Enhanced expression of monocyte tissue factor in patients with liver cirrhosis","volume":"43","author":"Saliola","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0620","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1160\/TH16-11-0857","article-title":"Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production","volume":"117","author":"Nocella","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.11.005_bb0625","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","article-title":"Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis","volume":"67","author":"Carnevale","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-5-13","article-title":"Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood","volume":"5","author":"Sucker","year":"2007","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2023.11.005_bb0635","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/01.ATV.17.3.465","article-title":"Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice in vivo","volume":"17","author":"Zhang","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0640","first-page":"6","article-title":"Ligustrazini inhibits endotoxin induced PAI-1 expression in human umbilical vein endothelial cells","volume":"21","author":"Ruan","year":"2001","journal-title":"J. Huazhong Univ. Sci. Technol. - Med. Sci."},{"key":"10.1016\/j.thromres.2023.11.005_bb0645","doi-asserted-by":"crossref","first-page":"R901","DOI":"10.1152\/ajpregu.00324.2014","article-title":"Endothelial cells but not platelets are the major source of Toll-like receptor 4 in the arterial thrombosis and tissue factor expression in mice","volume":"307","author":"Ren","year":"2014","journal-title":"Am. J. Physiol. - Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0650","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0655","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.lfs.2018.09.008","article-title":"ONO-5046 suppresses reactive oxidative species-associated formation of neutrophil extracellular traps","volume":"210","author":"Yao","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.thromres.2023.11.005_bb0660","first-page":"1","article-title":"JNK activation turns on LPS- and gram-negative bacteria-induced NADPH oxidase-dependent suicidal NETosis","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2023.11.005_bb0665","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2021.11.019","article-title":"Toll-like receptor 4 activation in platelets from myocardial infarction patients","volume":"209","author":"Barill\u00e0","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0670","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jtha.2022.11.022","article-title":"The mechanistic and structural role of von Willebrand factor in endotoxemia-enhanced deep vein thrombosis in mice","volume":"21","author":"Choi","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.11.005_bb0675","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/resp.12854","article-title":"Low-grade endotoxemia and clotting activation in the early phase of pneumonia","volume":"21","author":"Cangemi","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.thromres.2023.11.005_bb0680","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jinf.2016.05.013","article-title":"Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia","volume":"73","author":"Cangemi","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.thromres.2023.11.005_bb0685","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000348","article-title":"Low-grade Endotoxemia and thrombosis in COVID-19","volume":"12","author":"Oliva","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0690","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022482","article-title":"Genetic profile of endotoxemia reveals an association with thromboembolism and stroke","volume":"10","author":"Leskel\u00e4","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2023.11.005_bb0695","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2023.11.005_bb0700","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0705","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4254\/wjh.v7.i3.425","article-title":"Gut-liver axis in liver cirrhosis: how to manage leaky gut and endotoxemia","volume":"7","author":"Fukui","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0710","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2152307","article-title":"Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion","volume":"14","author":"Paone","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.thromres.2023.11.005_bb0715","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224838","article-title":"Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemia","volume":"14","author":"Di Caro","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.thromres.2023.11.005_bb0725","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fphar.2021.610164","article-title":"The punicalagin metabolites ellagic acid and urolithin a exert different strengthening and anti-inflammatory effects on tight junction-mediated intestinal barrier function in vitro","volume":"12","author":"Hering","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.thromres.2023.11.005_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104603","article-title":"Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-\u03baB pathway","volume":"152","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0735","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","article-title":"Statin therapy is associated with lower prevalence of gut microbiota dysbiosis","volume":"581","author":"Vieira-Silva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2023.11.005_bb0740","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.7150\/thno.55946","article-title":"Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.thromres.2023.11.005_bb0745","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00024382-200212000-00013","article-title":"Removal of phosphate from lipid a as a strategy to detoxify lipopolysaccharide","volume":"18","author":"Bentala","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.thromres.2023.11.005_bb0750","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.120.317144","article-title":"Over-expression of intestinal alkaline phosphatase attenuates atherosclerosis","volume":"128","author":"Ghosh","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103004","article-title":"A host lipase prevents lipopolysaccharide-induced foam cell formation","volume":"24","author":"Feng","year":"2021","journal-title":"IScience"},{"key":"10.1016\/j.thromres.2023.11.005_bb0760","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/gutjnl-2018-317609","article-title":"Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial","volume":"68","author":"Wan","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0765","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/j.gastro.2022.05.037","article-title":"Mediterranean-like dietary pattern associations with gut microbiome composition and subclinical gastrointestinal inflammation","volume":"163","author":"Turpin","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2023.11.005_bb0770","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","article-title":"Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome","volume":"70","author":"Bolte","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.thromres.2023.11.005_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800160","article-title":"The endotoxemia marker lipopolysaccharide-binding protein is reduced in overweight-obese subjects consuming pomegranate extract by modulating the gut microbiota: a randomized clinical trial","volume":"62","author":"Gonz\u00e1lez-Sarr\u00edas","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.thromres.2023.11.005_bb0780","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1160\/TH09-12-0856","article-title":"Serum albumin and risk of venous thromboembolism","volume":"104","author":"Folsom","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.11.005_bb0785","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2023.11.005_bb0790","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nutres.2022.04.001","article-title":"Trimethylamine N-oxide reduction is related to probiotic strain specificity: a systematic review","volume":"104","author":"Cantero","year":"2022","journal-title":"Nutr. Res."},{"issue":"2","key":"10.1016\/j.thromres.2023.11.005_bb0795","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02210-15","article-title":"Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota","volume":"7","author":"Chen","year":"2016","journal-title":"MBio"},{"issue":"7","key":"10.1016\/j.thromres.2023.11.005_bb0800","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008342","article-title":"Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome","volume":"7","author":"Smits","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2023.11.005_bb0805","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"108341","key":"10.1016\/j.thromres.2023.11.005_bb0810","first-page":"1","article-title":"3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice","volume":"78","author":"Wang","year":"2020","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.thromres.2023.11.005_bb0815","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/jcph.135","article-title":"Meldonium decreases the diet-increased plasma levels of trimethylamine N-oxide, a metabolite associated with atherosclerosis","volume":"53","author":"Dambrova","year":"2013","journal-title":"J. Clin. Pharmacol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:59Z","timestamp":1758736319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823003110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":163,"alternative-id":["S0049384823003110"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.11.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}